集団スクリーニングの世界市場レポート 2024

集団スクリーニングの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.8%の年間複合成長率（CAGR）で379億3,000万米ドルに成長すると予想されます。予測期間で予想される成長は、個別化医療への移行、慢性疾患の増加を伴う高齢化、ヘルスケアへの焦点の拡大など、いくつかの要因に起因すると考えられます。スクリーニングアクセス。この期間に予想される主な動向には、医療技術の進歩、ゲノミクスと精密スクリーニングの進化、遠隔医療と遠隔スクリーニングの注目度の高まり、多疾患スクリーニングパネルの開発、健康の公平性とアクセシビリティの重視が含まれます。これらの動向は、ヘルスケアの進化する情勢を総合的に反映しており、新たな課題や機会に対処するための革新的なアプローチが組み込まれています。

がんの罹患率の拡大により、集団スクリーニング市場の拡大が促進される見込みです。がんは、人体の特定の細胞が異常に発達し、体の他の領域に転移する状態を指します。 集団スクリーニングの取り組みは、治療がより効果的で予後が良好な早期段階でがんを検出する上で極めて重要な役割を果たします。たとえば、米国に本拠を置く任意の保健団体である米国がん協会によると、2023年には米国で推定196万人の新規がん患者が診断されると予測されており、これは確認された新規がん患者約190万人からの増加を反映しています。したがって、がんの有病率の増加は、集団スクリーニング市場の成長の触媒となります。

高齢者の割合の拡大により、集団スクリーニング市場の成長が促進されると予想されます。高齢者には、老化の過程にある人、または高齢のマイルストーンに達した人が含まれます。高齢者の特定の健康ニーズに合わせて調整された定期的な集団スクリーニングは、老化の成功と健康状態の改善に大きく貢献します。たとえば、2023年 6月、米国の政府機関である米国国勢調査局は、国の年齢中央値が0.2歳増加し、2022年には38.9歳に達すると報告しました。これは、人口内の継続的な高齢化傾向を示しています。したがって、高齢者の割合の増加が集団スクリーニング市場拡大の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の集団スクリーニング市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ハードウェア設備
• 検査またはラボ
• 分析または解釈
• 世界の集団スクリーニング市場、性別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 男性
• 女性
• 世界の集団スクリーニング市場、年齢別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 15歳未満
• 15-65歳
• 65歳以上
• 世界の集団スクリーニング市場、ビジネス別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 研究機関
• 診断研究所

第7章 地域および国の分析

• 世界の集団スクリーニング市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の集団スクリーニング市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 集団スクリーニング市場の競合情勢
• 集団スクリーニング市場の企業プロファイル
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Quest Diagnostics Incorporated

第31章 その他の大手および革新的な企業

• Eurofins Scientific SE
• Agilent Technologies Inc.
• Sonic Healthcare Limited
• Illumina Inc.
• SYNLAB International GmbH
• Quidel Corporation
• Bio-Rad Laboratories Inc.
• Unilabs
• Qiagen NV
• Exact Sciences Corporation
• ARUP Laboratories Inc.
• LGC Limited
• OPKO Health Inc.
• Natera Inc.
• Cerba HealthCare SAS

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Population screening is a systematic process aimed at evaluating the prevalence of a specific trait or disease within an entire population or a subgroup. The objective is to effectively identify individuals or groups at risk of developing a particular condition, distinguishing it from diagnostic testing.

The primary products associated with population screening include hardware equipment, testing or laboratory services, and analytics or interpretation tools. Hardware assumes a pivotal role in population screening by providing essential tools and equipment necessary for conducting screening tests, collecting data, and delivering healthcare services. Businesses engaged in population screening cater to various age groups, including males and females under 15, those between 15 and 65, and individuals aged 65 and above. These screening services are typically offered by a range of entities, including hospitals, research institutes, and diagnostic laboratories.

The population screening research report is one of a series of new reports from The Business Research Company that provides population screening market statistics, including the population screening industry's global market size, regional shares, competitors with population screening market share, detailed population screening market segments, market trends and opportunities, and any further data you may need to thrive in the population screening industry. This population screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The population screening market size has grown strongly in recent years. It will grow from $27.02 billion in 2023 to $29.12 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth observed in the historical period can be attributed to several factors, including disease prevention initiatives, government health policies, the escalation of healthcare costs, and heightened awareness of various diseases. These elements collectively contributed to the dynamics and trends influencing the healthcare landscape during the specified historical timeframe.

The population screening market size is expected to see strong growth in the next few years. It will grow to $37.93 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The anticipated growth in the forecast period can be attributed to several factors, including a shift towards personalized medicine, the aging population with a rise in chronic diseases, the integration of artificial intelligence (AI) and data analytics in healthcare, and an expanded focus on screening access. Key trends expected during this period encompass advancements in medical technology, the evolution of genomics and precision screening, the increasing prominence of telehealth and remote screening, the development of multi-disease screening panels, and a heightened emphasis on health equity and accessibility. These trends collectively reflect the evolving landscape of healthcare, incorporating innovative approaches to address emerging challenges and opportunities.

The escalating prevalence of cancer is poised to drive the expansion of the population screening market. Cancer represents a condition wherein particular cells within the human body undergo abnormal development and spread to other areas of the body. Population screening initiatives play a pivotal role in detecting cancer at early stages when treatments are more effective and prognosis is better. For example, as per the American Cancer Society, a voluntary health organization based in the United States, an estimated 1.96 million new cases of cancer are projected to be diagnosed in the US in 2023, reflecting an increase from the approximately 1.9 million new cases identified in 2021. Hence, the increasing prevalence of cancer stands as a catalyst for the growth of the population screening market.

The expanding proportion of aging individuals is anticipated to propel the growth of the population screening market. Aging individuals encompass those who are in the process of growing older or have reached advanced age milestones. Regular population screenings tailored to the specific health needs of aging individuals can significantly contribute to successful aging and better health outcomes. For instance, in June 2023, The United States Census Bureau, a governmental agency in the United States, reported a 0.2-year increase in the country's median age, reaching 38.9 years in 2022, indicating a continual aging trend within the population. Consequently, the growing proportion of aging individuals serves as a driving force behind the expansion of the population screening market.

Technological advancements have emerged as a pivotal and increasingly favored trend within the population screening market. Significant companies in this sector are embracing new technologies to uphold their market positions. An example of this occurred in May 2021, when Evoq Technologies LLC, a US-based enterprise specializing in innovative healthcare and biotechnology research, introduced SmartERG, the first phone-based retinal health testing platform. This device functions by emitting regulated light into the eye, capturing an electrical and physiological response from the retina. By identifying delays or reductions in visual responses, it detects potential retinal diseases that could lead to vision impairment or blindness. The platform offers cloud services with robust artificial intelligence (AI) and machine learning support, simplifying patient-provider connections and enhancing ophthalmic care.

Major companies operating in the population screening market are launching novel products specifically designed for disease screening to augment their market profitability. Disease-specific screening within population screening involves targeting individuals at risk for a particular disease within a larger population. For instance, in October 2023, DELFI Diagnostics, a US-based company specializing in advanced machine learning and fragmentomics, developed FirstLook Lung. This groundbreaking blood test utilizes whole-genome machine learning to analyze cell-free DNA fragments, serving as cancer markers. This user-friendly laboratory-developed test seamlessly integrates into routine blood screenings. Key features include a 99.7% negative predictive value, effectively ruling out the presence of lung cancer, and high sensitivity in detecting early-stage diseases. The test furnishes personalized, actionable reports to healthcare providers, presenting a potential solution to bolster the low screening rates for lung cancer in the United States.

In August 2021, Illumina Inc., a prominent US-based biotechnology company, successfully completed the acquisition of GRAIL for an undisclosed sum. This strategic move is anticipated to facilitate Illumina Inc. in broadening its range of cancer early-detection tests. GRAIL, the healthcare company based in the United States, specializes in the development of innovative technologies for early cancer detection with the overarching goal of saving lives and improving overall health.

Major companies operating in the population screening market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS

North America was the largest region in the population screening market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the population screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The population screening market consists of revenues earned by entities by providing services such as next-generation sequencing (NGS) and microarray-based genotyping, imaging tests, mammography screening, colonoscopy screening, cholesterol screening, and blood pressure screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The population screening market also includes sales of smartphone-based biosensors, kits, and chips, which are used in providing population screening services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Population Screening Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on population screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for population screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The population screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Hardware Equipment; Testing Or Lab; Analytics Or Interpretation
• 2) By Gender: Male; Female
• 3) By Age: Ages Less Than 15; 15-65; Ages 65 And Above
• 4) By Business: Hospitals; Research Institutes; Diagnostic Labs
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Quest Diagnostics Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Population Screening Market Characteristics

3. Population Screening Market Trends And Strategies

4. Population Screening Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Population Screening Market Size and Growth

• 5.1. Global Population Screening Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Population Screening Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Population Screening Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Population Screening Market Segmentation

• 6.1. Global Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hardware Equipment
• Testing Or Lab
• Analytics Or Interpretation
• 6.2. Global Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Male
• Female
• 6.3. Global Population Screening Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Ages Less Than 15
• 15-65
• Ages 65 And Above
• 6.4. Global Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Research Institutes
• Diagnostic Labs

7. Population Screening Market Regional And Country Analysis

• 7.1. Global Population Screening Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Population Screening Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Population Screening Market

• 8.1. Asia-Pacific Population Screening Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Population Screening Market

• 9.1. China Population Screening Market Overview
• 9.2. China Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Population Screening Market

• 10.1. India Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Population Screening Market

• 11.1. Japan Population Screening Market Overview
• 11.2. Japan Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Population Screening Market

• 12.1. Australia Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Population Screening Market

• 13.1. Indonesia Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Population Screening Market

• 14.1. South Korea Population Screening Market Overview
• 14.2. South Korea Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Population Screening Market

• 15.1. Western Europe Population Screening Market Overview
• 15.2. Western Europe Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Population Screening Market

• 16.1. UK Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Population Screening Market

• 17.1. Germany Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Population Screening Market

• 18.1. France Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Population Screening Market

• 19.1. Italy Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Population Screening Market

• 20.1. Spain Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Population Screening Market

• 21.1. Eastern Europe Population Screening Market Overview
• 21.2. Eastern Europe Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Population Screening Market

• 22.1. Russia Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Population Screening Market

• 23.1. North America Population Screening Market Overview
• 23.2. North America Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Population Screening Market

• 24.1. USA Population Screening Market Overview
• 24.2. USA Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Population Screening Market

• 25.1. Canada Population Screening Market Overview
• 25.2. Canada Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Population Screening Market

• 26.1. South America Population Screening Market Overview
• 26.2. South America Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Population Screening Market

• 27.1. Brazil Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Population Screening Market

• 28.1. Middle East Population Screening Market Overview
• 28.2. Middle East Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Population Screening Market

• 29.1. Africa Population Screening Market Overview
• 29.2. Africa Population Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Population Screening Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Population Screening Market, Segmentation By Business, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Population Screening Market Competitive Landscape And Company Profiles

• 30.1. Population Screening Market Competitive Landscape
• 30.2. Population Screening Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Thermo Fisher Scientific Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Abbott Laboratories
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Siemens Healthineers AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Quest Diagnostics Incorporated
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Population Screening Market Other Major And Innovative Companies

• 31.1. Eurofins Scientific SE
• 31.2. Agilent Technologies Inc.
• 31.3. Sonic Healthcare Limited
• 31.4. Illumina Inc.
• 31.5. SYNLAB International GmbH
• 31.6. Quidel Corporation
• 31.7. Bio-Rad Laboratories Inc.
• 31.8. Unilabs
• 31.9. Qiagen N.V.
• 31.10. Exact Sciences Corporation
• 31.11. ARUP Laboratories Inc.
• 31.12. LGC Limited
• 31.13. OPKO Health Inc.
• 31.14. Natera Inc.
• 31.15. Cerba HealthCare S.A.S

32. Global Population Screening Market Competitive Benchmarking

33. Global Population Screening Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Population Screening Market

35. Population Screening Market Future Outlook and Potential Analysis

• 35.1 Population Screening Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Population Screening Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Population Screening Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer